Kolon Life Science Inc. | Cash Flow
Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
17,228
5,855
800
12,665
1,404
Depreciation, Depletion & Amortization
7,111
9,361
9,235
9,479
11,238
Other Funds
2,687
608
3,337
3,227
1,754
Funds from Operations
27,026
15,825
13,373
25,372
8,080
Changes in Working Capital
10,865
3,730
7,435
2,739
16,373
Net Operating Cash Flow
16,161
12,095
20,807
28,111
8,293
Capital Expenditures
13,414
18,763
15,216
17,830
35,957
Sale of Fixed Assets & Businesses
-
7
107
32
2
Purchase/Sale of Investments
-
10,256
287
-
24,889
Net Investing Cash Flow
12,868
28,663
15,639
17,235
60,226
Cash Dividends Paid - Total
3,857
105
1,337
668
1,521
Issuance/Reduction of Debt, Net
1,169
5,667
18,169
13,685
11,666
Net Financing Cash Flow
554
1,682
16,832
99,611
13,187
Net Change in Cash
3,843
14,880
21,949
110,731
81,915
Free Cash Flow
4,375
2,912
8,400
11,972
38,271
Other Sources
1,028
467
178
652
659
Change in Capital Stock
3,242
7,455
-
113,965
-
Exchange Rate Effect
3
5
51
244
210
Other Uses
490
218
889
89
42
About Kolon Life Science
View Profile
